NaviMed Capital announced the expansion of its team with the addition of an experienced hospital executive as a Senior Advisor to the firm and the recent hiring of two investment Associates.
- NaviMed Capital Closes Fund II at $290 Million
- NaviMed Portfolio Company Velocity Clinical Research Acquired
- NaviMed Capital Announces Expansion of Investment and Operations Teams
- COVID-19 Vaccine Trial Starts Recruiting Patients, Including at Velocity Sites
- Argos Health Named Black Book’s Top Complex Claims Solutions Vendor for 2020